Guru Ownership Trend
Guru Analysis for Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $202.83 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $72.12 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Renaissance Technologies (RenTech) reduced exposure by 3.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Axsome Therapeutics, Inc. (AXSM)
Major holders include Steven Cohen ($71.79 M), Renaissance Technologies (RenTech) ($27.77 M), Cliff Asness ($17.59 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 859,577 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $72.12 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited AXSM. The total reported sell value was $963,414.
Yes, 1 managers opened new positions in AXSM, and 3 increased their existing holdings. The total reported buy value was $73.08 M.